deflazacort+grapefruit juice

Can You Take deflazacort and grapefruit juice Together?

Evidence-based clinical pharmacological assessment, adverse synergy evaluation, and administration separation protocols.

CRITICAL HAZARD: Potentially Severe or Contraindicated Combination

Co-administering deflazacort and grapefruit juice has documented pharmacodynamic or pharmacokinetic antagonism capable of triggering acute clinical harm. Do not combine without explicit specialist oversight.

Clinical Mechanism & Evidence Details

Potassium-Enriched Salt Substitutes & High-Potassium RegimensCRITICAL

Additive potassium retention risks hyperkalemia, which can lead to life-threatening cardiac dysrhythmias.

Grapefruit / Pomelo (CYP3A4 Inhibition)CRITICAL

Inhibits intestinal CYP3A4-mediated first-pass metabolism, elevating systemic drug concentrations and increasing toxic adverse effect risks.

Statins, Calcium Channel Blockers, Immunosuppressants & PDE5 InhibitorsCRITICAL

Furanocoumarins irreversibly destroy enterocyte CYP3A4 enzymes for up to 72 hours, elevating systemic drug bioavailability into toxic ranges.

Alcohol / EthanolHIGH

Alcohol may enhance gastrointestinal irritation, trigger orthostatic hypotension, or alter drug absorption kinetics.

MedlinePlus Dietary GuidanceMEDIUM

Your doctor may instruct you to follow a low-salt or a diet high in potassium or calcium. Your doctor may also prescribe or recommend a calcium or potassium supplement. Follow these directions carefully.

Recommended Administration Timing Window
May form unabsorbable gastrointestinal chelates or compete for active mucosal transport. Separate administration by at least 2 to 4 hours.
Comprehensive Personal Stack Evaluation

Taking other supplements, foods, or medications with this pair?

Add your morning coffee, daily multivitamins, prescription pills, and dinner foods into our instant browser-based radar to check for multi-way chain reactions.

Launch SafeStack Radar with deflazacort + grapefruit juice→
Authoritative Regulatory Citations

Clinical mechanism and interaction severity derived from openFDA Drug Structured Product Labeling (Section 7), NIH Office of Dietary Supplements (ODS), and NIH NCCIH clinical botanicals database.